✦ LIBER ✦

Comparison between IFNalpha2a + ribavirin and IFNalpha2a + amantadine combination therapy in naive patients with chronic hepatitis C-genotype 1, and between amantadine and ribavirin addition in non responders after 3 months

✍ Scribed by Antonio Bellobuono; R. Finazzi; G. Covini; L. Milazzo; C. Magni; A.M. Milella; C. Janoletti; F. Bozzetti; Andrea Bellobuono; G. Idéo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction doses of interferon-α-2a in co

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

574 Association between liver histology,

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

A 3-ARM randomized study evaluating the

✍ Alessandra Mangia; Giovanni Ricci; Nicola Minerva; Marcello Persico; Vito Carret 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB

P.275 Influence of genotype, viral load

✍ H. Cheinquer; M. Pessoa; H. Sette Jr.; E. Parise; R. Paraná; F. Tatsch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Interferon alpha-2b and ribavirin in com

✍ Giuseppe Barbaro; Gabriella Di Lorenzo; Giancarlo Belloni; Luisella Ferrari; Ald 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Prediction of nonSVR to therapy with peg

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB